Apotex Case Shows Inequitable Conduct Is Still A Potent Tool

A recent Federal Circuit ruling that an Apotex Inc. patent is unenforceable because of misconduct by the company's chairman makes clear that although a 2011 decision made inequitable conduct very difficult to prove, the defense can still deliver sweeping ...read more

  • Tags: